deltatrials
Completed OBSERVATIONAL NCT05080231

COVID-19 Immunity Assessment

Blood Specimen Collection for COVID-19 Immunity Assessment Mailer Kit Clinical Study

Sponsor: DxTerity Diagnostics

Conditions COVID-19
Updated 4 times since 2021 Last updated: Aug 8, 2023 Started: Jul 15, 2021 Primary completion: Sep 10, 2021 Completion: Sep 10, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19, this trial is completed. The trial is conducted by DxTerity Diagnostics and has accumulated 4 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Nov 2021 – ~Sep 2023 · 22 months · monthly snapshotActive Not Recruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Sep 2023 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  4. Nov 2021 — Sep 2023 [monthly]

    Active Not Recruiting

    First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • DxTerity Diagnostics
Data source: DxTerity Diagnostics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations